HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Shinichi Hasegawa, Speaker at Oncology Conferences
Hasegawa Medical Clinic, Japan

Abstract:

Objective: It remains unclear whether the priority of nodal dissection is different depending on Types II and III.

Methods: The priority was evaluated by the therapeutic index, calculated by multiplying of the incidence of metastasis to each station by 5-year survival rate.

Results: A total of 176 patients (95 Type II and 81 Type III) were examined. The stations showing the first to fourth highest index were the right and left paracardial nodes (#1 and #2), lesser curvature node (#3), and the node at the root of the left gastric artery (#7) in the total cohort, as well as in each type. The fifth highest station in type II was the lower thoracic para-esophageal lymph node (#110), followed by the node along the proximal splenic artery (#11p), while that in type III was the node along the proximal splenic artery (#11p) followed by the para-aortic node (#16a2), the node at the celiac artery (#9), and the node around the splenic hilum (#10).

Conclusions: These results suggest that the highest priority nodal stations to be dissected were #1, #2, #3, and #7 regardless of the Siewert subtype, but the subsequent priority was different depending on the subtype.

Biography:

Professor Shinichi Hasegawa graduated from Yokohama City University and completed his M.D. degree in 1999, and Ph.D.degree in 2009. He was a Japanese gastrointestinal surgeon, and his research was focused on upper GI cancer, in particular, "adenocarcinoma of the esophago-gastric juntion (AEG)". He conducted some clinical trials as a surgeon in Yokohama City University and Kanagawa Cancer Center. Moreover, he was also board-certified in medical oncology and served the cancer treatment of both surgery and chemotherapy as a medical oncologist. He is currently a director of Hasegawa Medical Clinic, and also an appointed Lecturer as a Professor at Yokohama City University.

Facebook Twitter XTwitter Youtube
Watsapp